Doo Sang Cho
Gastroenterology · Mesa, AZNPI 1750376778
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 25.5% of the total. Reporting peaked in 2019 at $848 and has fallen 96.8% since, to $27 in 2024. That places this record below the midpoint for gastroenterology clinicians in AZ, where the typical reported total is $3,568.
Across 70 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$309
- Gilead$252
- Takeda Pharmaceuticals U.S.A., Inc.$174
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$78
- Johnson & Johnson$77
- Pfizer$58
- plus $267 from 10 others
Across 61 payments — averaging $5125.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$111K
- Intercept Pharmaceuticals, Inc.$85K
- Eli Lilly$77K
- Shire North American Group Inc$35K
- Takeda Pharmaceuticals U.S.A., Inc.$5K
What the payments were for
- Food & beverage$1,216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $309 |
| Gilead | 11 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $174 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $78 |
| Johnson & Johnson | 6 | $77 |
| Pfizer | 4 | $58 |
| Daiichi Sankyo Inc. | 3 | $49 |
| Shionogi Inc | 3 | $42 |
| UCB, Inc. | 2 | $34 |
| Intercept Pharmaceuticals, Inc. | 2 | $30 |
| Braintree Laboratories, Inc. | 2 | $29 |
| Abbott | 1 | $27 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Shire North American Group Inc | 1 | $13 |
| Merck | 1 | $12 |
| QOL Medical, LLC | 1 | $11 |
How this compares
$1,216 in reported general payments places this provider in the 30th percentile of 355 gastroenterology providers in Arizona.
Other gastroenterology in Mesa
- David LeffMesa$377K
- David TesslerMesa$191K
- Elisa FaybushMesa$30K
- Shahbaz QureshiMesa$25K
- Charles SapersteinMesa$25K
- Carlos Zapata AntigoniMesa$25K
- George WalkerMesa$15K
- Joel BrillParadise Valley$847K
- Daniel MelineScottsdale$795K
- David FleischerScottsdale$410K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.